Bortezomib depended on PRDM1 and TP53 to exert therapeutic effect in activated B-cell-like diffuse large B-cell lymphoma

Detalles Bibliográficos
Autores principales: Tang, Jing, Li, Yue, Wu, Jiazhu, Shen, Haorui, Yin, Hua, Liang, Jinhua, Wang, Li, Li, Jianyong, Xia, Yi, Xu, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Chongqing Medical University 2023
Materias:
Rapid Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10491910/
https://www.ncbi.nlm.nih.gov/pubmed/37692509
http://dx.doi.org/10.1016/j.gendis.2023.04.012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10491910/
https://www.ncbi.nlm.nih.gov/pubmed/37692509
http://dx.doi.org/10.1016/j.gendis.2023.04.012

Ejemplares similares